Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 249

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 249
---
 to the terms of the Securities Purchase Agreement by and between
A SPAC I Mini Acquisition Corp. and certain investors named therein (the “February Buyers”) on February 29, 2024. Pursuant
to this Securities Purchase Agreement, A SPAC I Mini Acquisition Corp agreed to issue and sell to the February Buyers, in a private placement,
an aggregate of up to $3,500,000 principal amount of convertible notes, consisting of one or more tranches: (i) an initial tranche of
an aggregate principal amount of promissory notes of up to $1,750,000 and including an original issue discount of up to aggregate $122,500,
and (ii) subsequent tranches of an aggregate principal amount of promissory notes of up to $1,750,000 and including an original issue
discount of up to aggregate $122,500. The closing of the Initial Tranche took place on April 3, 2024. The Company also closed on a subsequent
tranche of the aforementioned promissory notes in the principal amount of $250,000 by issuing and selling to the February Buyers shortly
after the closing of the Business Combination, resulting in an aggregate principal amount of notes of $2,000,000 sold to the February
Buyers. The form of these promissory notes is included as Exhibit 4.2 of the Form 6-K filed on April 4, 2024. The aforementioned Securities
Purchase Agreement is included as Exhibit 4.1 of the Form 6-K filed on April 4, 2024.

2024 Debt Financing

On August 7, 2024, the Company
entered into a Securities Purchase Agreement (“Securities Purchase Agreement”) with certain investors named therein (collectively,
the “Buyers”), pursuant to which, amongst other things: (i) the Company agreed to sell, at an initial closing (and such initial
closing, the “Initial Closing”), (a) a senior convertible note (the “Initial Note”) in the aggregate original
principal amount not exceeding $1,100,000, convertible into Class A Ordinary Shares pursuant to its terms, (b) a warrant to purchase 1,325,301
Class A Ordinary Shares (such warrant, the “Series A Warrant” and prior to any Reverse Stock Splits), and (c) a warrant to
purchase 180,722 Class A Ordinary Shares (the “Series B Warrant” and prior to any Reverse Stock